Research & Applications

The International Atomic Energy Agency is developing multiple methods to rapidly screen and authenticate the origin of foods like extra virgin olive oil. With recent heat waves and droughts affecting olive oil yields in Europe—which produces 60 percent of all olive oils—the European Commission has a problem: a growing black market in fake virgin and extra virgin olive oils. According to a 2022 EC report, olive oil is one of the most mislabeled food products in Europe.

Type One Energy Group announced plans on February 21 to relocate its headquarters from Madison, Wis., to the Tennessee Valley Authority’s (TVA) Bull Run fossil plant in Clinton, Tenn., where it will build a stellarator fusion prototype machine. According to the company, the construction of the stellarator—called Infinity One—could begin in 2025, if necessary environmental reviews, partnership agreements, permits, and operating licenses are all in hand.

Kairos Power announced on February 21 that it has signed a technology investment agreement with the Department of Energy to implement the Advanced Reactor Demonstration Program (ARDP) Risk Reduction funding that the company was awarded in December 2020. Under the agreement, the DOE will provide up to $303 million to Kairos Power using a performance-based, fixed-price milestone approach to support the design, construction, and commissioning of the Hermes demonstration reactor in Oak Ridge, Tenn.

After nearly eight years of valuable service as editor of the American Nuclear Society journal Fusion Science and Technology, Leigh Winfrey has indicated that she intends to step down from the position as of June 2025, providing an opportunity for a fresh voice to lead FST. Consequently, ANS is seeking a qualified individual to fill this position.

The role of the editor is primarily technical leadership, setting the direction of the journal by soliciting papers, special issues, and reviews on important and timely technical topics. The editor also oversees the peer review of submitted papers and decides on acceptance, revision, or rejection.

As hydrogen production increases worldwide, some see clean hydrogen as a game-changer when it comes to decarbonizing the steel industry.

Steel production is one of the “hard-to-abate” sectors of industry, which are responsible for about 30 percent of global carbon emissions. These industries are tough to decarbonize because the technologies either do not yet exist or are considered uneconomical.

America, Japan, and China are racing to be the first nation to make nuclear energy completely renewable. The hurdle is making it economical to extract uranium from seawater, because the amount of uranium in seawater is truly inexhaustible.

While America had been in the lead with technological breakthroughs from the Department of Energy’s Pacific Northwest and Oak Ridge National Laboratories, researchers at Northeast Normal University in China have sprung ahead. But these breakthroughs from both countries have brought the removal of uranium from seawater within economic reach. The only question is when will the source of uranium for our nuclear power plants change from mined ore to sea­water extraction?

On August 2, 1946, 1 millicurie of the isotope carbon-14 left Oak Ridge National Laboratory, bound for the Barnard Free Skin and Cancer Hospital in St. Louis, Mo.

That tiny amount of the radioisotope was purchased by the hospital for use in cancer studies. And it heralded a new peacetime mission for ORNL, built just a few years earlier for the production of plutonium from uranium for the Manhattan Project.

PanTera, a Belgian joint venture created by Ion Beam Applications (IBA) and SCK CEN, has signed a capacity reservation agreement with pharmaceutical giant Bayer for the supply of actinium-225 starting in the second half of 2024. An alpha-emitting radioisotope with a half-life of 10 days, Ac-225 has shown potential for treating various types of cancer through targeted alpha therapy.

The Department of Energy announced February 7 that fuel for the MARVEL microreactor, which Idaho National Laboratory plans to host inside the Transient Reactor Test (TREAT) facility, is now being fabricated by TRIGA International, with the first fuel delivery expected in spring 2025. MARVEL operation was expected “by the end of 2024” as recently as May 2023, but that timeline had shifted by October, when the DOE said MARVEL “is expected to be completed in early 2025.” Now, according to the DOE’s latest announcement, “Fuel loading for MARVEL is anticipated to occur in 2026, with the microreactor expected to be on line by 2027.”

According to the Council on Radionuclides and Radiopharmaceuticals, more than 82,000 nuclear imaging procedures using nuclear medicine are performed throughout the world every day. To administer these vital medical procedures, radiopharmaceutical companies and hospitals rely on a handful of producers of medical radioisotopes.

Idaho National Laboratory announced on January 31 that it is expanding its research partnership with the Colorado School of Mines (Mines). Representatives from the two institutions signed a memorandum of understanding in October that outlines a framework for collaboration on research into energy storage, high-temperature fuel cells, geothermal energy systems, the nuclear fuel cycle and reactor engineering, environmental science, and next-generation mining science and engineering.

Zeno Power announced on January 26 that it will get the strontium-90 that it needs to fuel full-scale radioisotope power systems (RPSs) for national security and space exploration missions from the Department of Energy’s Oak Ridge Office of Environmental Management (OREM). Under a public-private partnership, a large legacy RPS known as the BUP-500 that had languished, unused, in storage at Oak Ridge National Laboratory has been transported to an unnamed commercial radiological facility in Pennsylvania—Zeno Power’s subcontractor—where the Sr-90 it contains will be repurposed as heat sources for Zeno Power devices.

More people in low- and middle-income countries who have head and neck cancer may be able to access lifesaving radiotherapy after research supported by the International Atomic Energy Agency has shown that fewer—but higher—doses of radiation treatment resulted in clinical outcomes similar to standard radiotherapy treatments. Reducing overall treatment times for this type of cancer through a treatment regimen called hypofractionation could help countries navigate resource constraints and shorten waitlists, enabling more patients to receive treatment while also reducing the cost and duration of care. The IAEA announced the findings in a news article published January 22.

Two teams of guest editors from Idaho National Laboratory have announced plans for special issues of Nuclear Science and Engineering, the nuclear field’s longest-running technical journal. Abdalla Abou Jaoude and Abderrafi M. Ougouag are leading the issue on Technical Challenges and Opportunities in the Development and Deployment of Microreactors, while Joseph Nielsen and Piyush Sabharwall are organizing the issue on Irradiation Experiments Supporting Advanced Nuclear Technologies.

Designs for high-tech products, and the start-ups that offer them, will always outnumber the commercial successes. Ditto: many more power plants are proposed than actually get built, no matter what the technology.

This is an axiom of free-market economies, but in early November 2023 it became painfully obvious in the advanced reactor field. NuScale Power, the only advanced reactor that has made it through the licensing gauntlet, acknowledged that the consortium of utilities that was its intended launch customer had failed to put together a feasible package.

Argonne’s newest beamline uses heavy ions to degrade a material’s properties as much in a day as a nuclear reactor does in a year, without introducing radioactivity. That’s according to an article published January 16 by Argonne National Laboratory. The Argonne Tandem Linac Accelerator System (ATLAS) now boasts a new beamline—the ATLAS Material Irradiation Station, or AMIS—that uses the accelerator’s lowest high-energy beams to displace atoms and mimic the degradation of materials inside an operating reactor over time. AMIS makes it easier and faster to test candidate fuel and structural materials for existing and future reactors.

A growing number of institutional, national, and funder mandates are requiring researchers to make their published work immediately publicly accessible, through either open repositories or open access (OA) publications. In addition, both private and public funders are developing policies, such as those from the Office of Science and Technology Policy and the European Commission, that ask researchers to make publicly available at the time of publication as much of their underlying data and other materials as possible. These, combined with movement in the scientific community toward embracing open science principles (seen, for example, in the dramatic rise of preprint servers like arXiv), demonstrate a need for a different kind of publishing outlet.

The International Atomic Energy Agency, in cooperation with Argentina, launched a scientific research expedition on January 6 to study microplastics in Antarctica—one of the planet’s most remote areas—as part of an effort to combat widespread microplastic pollution.

A new material based on amidoxime chemical groups may allow electrochemical extraction technology to extract uranium ions from seawater more efficiently than previous methods, according to a recent study published by the American Chemical Society’s ACS Central Science. If put into practical use, the new method, which was developed by researchers in China, could offer an environmentally sustainable source of fuel for nuclear power plants.

Radiopharmaceutical biotech company ITM Isotope Technologies Munich announced it has received regulatory approval to begin production of the medical radioisotope lutetium-177 at the company’s NOVA facility in Neufahrn, near Munich, Germany.